NORTCQUIMICA (NRTQ3) Main Indicators
Basic Data - NRTQ3
| Company | NORTCQUIMICA |
| Corporate Name | NORTEC QUÍMICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Tradicional - BOVESPA |
| Activity | Química Fina. Ciências da Vida. fabricantes de Insumos Farmacêuticos Ativos - matéria-prima para a Indústria Farmacêutica |
| Share | NRTQ3 |
| Quote Date | NA |
| Share Type | ON |
| Last Closing | NA |
| Quotation Factor | NA |
| Financial Volume | NA |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Medicamentos e Outros Produtos |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | - |
| Updated 04/02/2025 | |
Relative Prices - NRTQ3
| Price/Earnings | 0.00 |
| Price/SBV | 0.00 |
| Price/Net Sales | 0.00 |
| Price/CFO | 0.00 |
| Price/FCF | 0.00 |
| Price/Total Assets | 0.00 |
| Price/EBIT | 0.00 |
| Price/Working Capital | 0.00 |
| Price/NCAV | 0.00 |
| EV/EBIT | NA |
| EV/EBITDA | NA |
| EV/Net Sales | NA |
| EV/CFO | NA |
| EV/FCF | NA |
| EV/Total Assets | NA |
| Company Market Cap | NA |
| Enterprise Value | NA |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 0.00 |
| Share Price Date | //0 |
| Dividend Yield | 0.00% |
| Updated 04/02/2025 | |
Income Statement - NRTQ3
| Net Revenue | R$ 245.83 M |
| Gross Result | R$ 66.47 M |
| EBIT | R$ 24.79 M |
| Depreciation and Amortization | - R$ 12.65 M |
| EBITDA | R$ 37.43 M |
| Net Profit | R$ 9.01 M |
| Net Profit/Share | R$ 0.76 |
| Updated 03/28/2025 | |
| Net Revenue | R$ 72.49 M |
| Gross Result | R$ 22.75 M |
| EBIT | R$ 10.63 M |
| Depreciation and Amortization | - R$ 3.09 M |
| EBITDA | R$ 13.72 M |
| Net Profit | R$ 3.02 M |
| Profit/Share | R$ 0.25 |
| Updated 03/28/2025 | |
Price and Volume Behavior - NRTQ3
There are no quotes for this ticker.
Returns and Margins - NRTQ3
| Return on Initial Tangible Capital | 6.46% |
| Return on Initial Invested Capital | 6.51% |
| Pre-Tax Return on Initial Tangible Capital | 9.78% |
| Pre-Tax Return on Initial Invested Capital | 9.86% |
| Return on Initial Shareholder´s Equity | 3.88% |
| Return on Initial Asset | 2.72% |
| Gross Margin | 27.04% |
| Net Margin | 3.67% |
| EBIT Margin | 10.08% |
| EBITDA Margin | 15.23% |
| Initial Asset Turnover | 0.74 |
| Financial Leverage | 1.64 |
| Liabilities/Net Worth | 0.64 |
| Net Debt/EBITDA | 2.19 |
| Updated 03/28/2025 | |
Balance Sheet - NRTQ3
| Cash and Cash Equivalents | R$ 27.60 M |
| Total Assets | R$ 392.32 M |
| Short-Term Debt | R$ 10.68 M |
| Long-Term Debt | R$ 98.75 M |
| Gross Debt | R$ 109.43 M |
| Net Debt | R$ 81.83 M |
| Shareholder´s Equity | R$ 239.68 M |
| Share Book Value | R$ 20.18 |
| Common Shares | 11,877,000 |
| Preferred Shares | 0 |
| Total | 11,877,000 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 11,877,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 11,877,000 |
| Updated 03/28/2025 | |
Cash Flow - NRTQ3
| Operating Cash Flow | R$ 11.37 M |
| Cash Flow from Investments | - R$ 21.07 M |
| Financing Cash Flow | - R$ 3.48 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 13.18 M |
| Updated 03/28/2025 | |
| Operating Cash Flow | R$ 10.39 M |
| Cash Flow from Investments | - R$ 6.64 M |
| Financing Cash Flow | - R$ 4.12 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 365.00 thousand |
| Updated 03/28/2025 | |
Experimental - NRTQ3
| CAPEX 3 months | - R$ 4.33 M |
| Free Cash Flow 3 months | R$ 6.06 M |
| CAPEX 12 months | - R$ 21.63 M |
| Free Cash Flow 12 months | - R$ 10.26 M |
| Updated 03/28/2025 | |
Quote Chart - NRTQ3
There are no quotes for this ticker.